Navigation Links
Experimental Malaria Vaccine Shows Results

A new experimental vaccine developed by scientists in the US attacks the malaria parasite in its early stages and could help prevent the disease that has kills one million// people a year.

The new vaccine -- called RTS, S and developed by Walter Reed Army Institute of Research -- reduced the number of clinical malaria episodes by 26 percent for up to 18 months after vaccination among children in Mozambique, where malaria is common, reported the science portal EurekAlert.

There were 58 percent fewer severe episodes among the children over the same time period. The vaccine also reduced the number of clinical malaria episodes in partially immune men in Gambia by 63 percent after they received a booster shot a year later, it said.

The Cochrane Collaboration, an organisation that reviews clinical trials of the vaccine, found that it protected 41 percent of volunteers in the US who were exposed to malarial mosquitoes in the lab.

The RTS, S vaccine showed extremely promising results, the researchers said. The review appears in the latest issue of The Cochrane Library, a publication of The Cochrane Collaboration.

Malaria is a parasite carried by mosquitoes and kills at least a million people a year, especially children in Africa. It increasingly resists anti-malarial drugs, according to a report in the online edition of New Scientist.

Efforts to develop a vaccine have been frustrated because the parasite changes its form several times during an infection.

These changes alter the surface chemicals that vaccines normally exploit to prime the immune system to recognise a pathogen. Scientists are divided over which stage to vaccinate against.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Experimental treatment for Ebola Virus Shows promising results in mice
2. Experimental drug to fight flu
3. Experimental SARS Vaccine
4. Experimental vaccine for shingles is effective
5. Experimental Blood Test May Spot Heart Attack Risk, Study Says
6. Five AIDS Patients To Receive Experimental Anti-retroviral Drugs
7. Protection against HIV and Herpes is possible with the Experimental Microbicide
8. Experimental Therapy Effective Against Malignant Melanoma in Horses
9. Experimental Alzheimer’s Drug curbs the disease in mic
10. New Guidelines to Be Laid While Testing Experimental Drugs
11. Experimental Drug Deals Effectively with Prostate Cancer Cells
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)... ... ... A recent video posting of a new fidget product gathered online momentum as ... stress and anxiety. No one was more surprised than Think Ink Pen founders ... successful Kickstarter campaign raising $67,000 on the popular crowdfunding platform. “We’ve been in ...
(Date:1/18/2017)... ... January 18, 2017 , ... Visually ... number one doctor-recommended OTC antiperspirant, Certain Dri. , Excessive sweating and hyperhidrosis are ... Dri created this infographic to explain the seven types of hyperhidrosis. This visual ...
(Date:1/18/2017)... (PRWEB) , ... January 18, ... ... specialty pharmacy industry’s leading journal and most-read publication among specialty pharmacists and ... Medical Center through its Strategic Alliance Partnership (SAP) program, announced Brian Haug, ...
(Date:1/18/2017)... ... January 18, 2017 , ... PrideStaff, a national, ... Franchise Development, Paula Turner Pizarro, was recently featured on Fox Business Network's Worldwide ... of top business leaders from across the globe, provides viewers an opportunity to ...
(Date:1/18/2017)... ... ... At Hallmark Nameplate, their commitment to quality is what sets them apart. The company ... is another way they are making constant strides to provide all customers with the ... ISO 13485 Certification is a major accomplishment for Hallmark Nameplate and will allow the ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017   Synthetic Biologics, Inc. (NYSE ... designed to preserve the microbiome to protect and ... to initiate a Phase 2b/3 adaptive pivotal trial ... lactone designed to reduce methane production by certain ... to treat the underlying cause of irritable bowel ...
(Date:1/18/2017)... PAUL, Minn. , Jan. 18, 2017 /PRNewswire-USNewswire/ ... developer of medical devices using neuroblocking technology to ... today announced the pricing of an underwritten public ... million, prior to deducting underwriting discounts and commissions ... The offering is comprised of Class A Units, ...
(Date:1/18/2017)... PHILADELPHIA , Jan. 18, 2017 The Philadelphia ... three companies developing medical devices for children. The Consortium ... to receive seed grants of $50,000 each. The ... amplifies weak nerve signals, a hand-operated rapid blood delivery system ... ears in babies. ...
Breaking Medicine Technology: